1. Major research papers retracted over data controversy

    Major research papers retracted over data controversy

    Date

    Health Report on ABC Radio National - Scientists have raised concerns about the data underlying a number of major coronavirus research papers, causing two of the world's biggest medical journals.

  2. An open letter from 119 scientists and researchers to The Lancet

    An open letter from 119 scientists and researchers to The Lancet

    Date

    Signed by clinicians, medical researchers, statisticians, and ethicists from across the world, follows the publication of a paper on using hydroxychloroquine or chloroquine for the treatment of COVID-19.

  3. Innovative data use an important step in eliminating hep B

    Innovative data use an important step in eliminating hep B

    Date

    A team of researchers in the Northern Territory (NT) have designed and tested a new algorithm to determine hepatitis B status.

  4. Q&A with infectious diseases expert Professor Josh Davis

    Q&A with infectious diseases expert Professor Josh Davis

    Date

    Professor Josh Davis is a clinician researcher, and divides his time between clinical work as an infectious diseases physician in Newcastle, and research work as a senior principal research fellow based at Menzies. He is also the President of the...

  5. Coronavirus assistance to Pacific and Timor-Leste

    Coronavirus assistance to Pacific and Timor-Leste

    Date

    Coronavirus [COVID-19] is now affecting 75 countries, with the total number of cases over 90,000 and the global death toll at more than 3000.

  6. Coronavirus assistance to Pacific and Timor-Leste

    Coronavirus assistance to Pacific and Timor-Leste

    Date

    Coronavirus [COVID-19] is now affecting 75 countries, with the total number of cases over 90,000 and the global death toll at more than 3000.

  7. CAMERA2: Standard MRSA treatment does not outperform combination therapy

    CAMERA2: Standard MRSA treatment does not outperform combination therapy

    Date

    Standard treatment for Methicillin-resistant Staphylococcus aureus (MRSA) infection is not more efficacious than combination therapy, according to new research published in JAMA.

  8. Trial shows using two drugs not better than one when treating MRSA blood infections

    Trial shows using two drugs not better than one when treating MRSA blood infections

    Date

    Researchers attempting to improve the treatment for methicillin-resistant Staphylococcus aureus (MRSA) blood infections have discovered the combination of two antibiotics was no better than one, and led to more adverse effects.

  9. Trial shows using two drugs not better than one when treating MRSA blood infections

    Trial shows using two drugs not better than one when treating MRSA blood infections

    Date

    Researchers of methicillin-resistant Staphylococcus aureus (MRSA) blood infections say combination of two antibiotics was no better than one.

  10. Study supports minimal monitoring in Sofosbuvir-based therapy for HCV

    Study supports minimal monitoring in Sofosbuvir-based therapy for HCV

    Date

    Some patients receiving sofosbuvir-based therapy for hepatitis C virus (HCV) may not need standard monitoring with clinic visits and blood testing.

  11. PhD Expression of Interest | Camera 2 Study

    PhD Expression of Interest | Camera 2 Study

    Date

    We are looking for EOI for an ID / microbiology fellow to conduct follow-on studies from CAMERA2 as part of a PhD.

  12. ASID Annual Scientific Meeting deemed a success for NT

    ASID Annual Scientific Meeting deemed a success for NT

    Date

    The Australasian Society for Infectious Diseases (ASID) Annual Scientific Meeting 2019, held from 16–18 May, saw 450 attendees descend on the Darwin Convention Centre.

  13. Combination Therapy for MRSA Bloodstream Infections: Still a Question Mark

    Combination Therapy for MRSA Bloodstream Infections: Still a Question Mark

    Date

    In an editorial by Thomas Holland, at Duke University School of Medicine, and Prof Joshua Davis, at Menzies highlighted the significance of the new study’s findings in the larger context.

  14. The winner takes it all  for S. aureus

    The winner takes it all for S. aureus

    Date

    The CAMERA2 study, executed in multiple countries addressing the question whether addition of a beta-lactam antibiotic (7 days) improves outcome in patients with MRSA bacteremia.

  15. Two New Trials of Combination Therapy for MRSA Bacteremia

    Two New Trials of Combination Therapy for MRSA Bacteremia

    Date

    The CAMERA2 study, just presented by Steven Tong at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

  16. CAAMA Podcast | Strong Voices Monday 25/09/2019

    CAAMA Podcast | Strong Voices Monday 25/09/2019

    Date

    Australian researchers have used current Hepatitis B virus genome sequences to map the movement of Aboriginal people into Australia. A senior research fellow at the Menzies school of health research discusses the research paper.

  17. Hepatitis B DNA Helps Trace History and Movement of First Australians

    Hepatitis B DNA Helps Trace History and Movement of First Australians

    Date

    The team found that hepatitis B virus isolated from these Aboriginal Australians is a unique strain called HBV/C4, which is not found anywhere else in the world.

  18. Hepatitis B virus sheds light on ancient human population movements

    Hepatitis B virus sheds light on ancient human population movements

    Date

    LongRoom News | Australian researchers have used current hepatitis B virus (HBV) genome sequences to deduce ancient human population movements into Australia.

  19. Hepatitis B virus sheds light on ancient human population movements

    Hepatitis B virus sheds light on ancient human population movements

    Date

    LongRoom News | Australian researchers have used current hepatitis B virus (HBV) genome sequences to deduce ancient human population movements into Australia.

  20. Hepatitis B virus sheds light on ancient human population movements into Australia

    Hepatitis B virus sheds light on ancient human population movements into Australia

    Date

    Australian researchers have used current hepatitis B virus (HBV) genome sequences to deduce ancient human population movements into Australia, adding weight to the theory that the mainland Aboriginal population separated from other early humans at least 59 thousand years ago and possibly entered the country near the Tiwi Islands.

  21. Menzies researcher gains national recognition

    Menzies researcher gains national recognition

    Date

    Menzies Professor Josh Davis has been awarded a Research Excellence Award at the NHMRC annual awards dinner in Canberra.

  22. Uptake of revolutionary hepatitis drugs lowest in areas of greatest need | ABC AM

    Uptake of revolutionary hepatitis drugs lowest in areas of greatest need | ABC AM

    Date

    The Northern Territory has the highest rate of hepatitis C in the country. But research by the Doherty Institute shows it has the second lowest rate of uptake of drugs that cure the disease.

  23. Combination Therapy in Treating S. aureus Infections

    Combination Therapy in Treating S. aureus Infections

    Date

    Prof. Josh Davis, MBBS, PhD, Principle Research Fellow, Menzies School of Health Research, Australia, discusses the role of combination therapy when it comes to treating invasive Staphylococcus aureus infections.

  24. RISE OF ANTIMICROBIAL RESISTANCE “DEEPLY ALARMING”

    RISE OF ANTIMICROBIAL RESISTANCE “DEEPLY ALARMING”

    Date

    THE death of an American woman from an untreatable infection with a gram-negative bacterium resistant to all classes of antibiotics has left Australian infectious diseases experts “deeply alarmed”, according to an editorial published in the Medical Journal of Australia.

  25. MJA Podcast on the clinical experience of patients with hepatitis C virus infection.

    MJA Podcast on the clinical experience of patients with hepatitis C virus infection.

    Date

    Associate Professor Joshua Davis is a Principal Research Fellow with the Menzies School of Health Research. He is the coauthor of a Short Report on the clinical experience of patients with hepatitis C virus infection among Australian GP trainees.

  26. Severe hep B strain afflicts indigenous population

    Severe hep B strain afflicts indigenous population

    Date

    INDIGENOUS Territorians with hepatitis B suffer from an aggressive strain of the virus not found anywhere else in the world, researchers from Menzies School of Health Research have found.

  27. Drug-Resistant Golden Staph Breakthrough Tested By Volunteer Australian Doctors

    Drug-Resistant Golden Staph Breakthrough Tested By Volunteer Australian Doctors

    Date

    When strains of the potentially deadly golden staph bacteria stopped responding to antibiotics in the 1960s, doctors scrambled to find a solution.

  28. Defeating serious MRSA infections using an everyday drug that shouldn’t work

    Defeating serious MRSA infections using an everyday drug that shouldn’t work

    Date

    A new drug combination is the first step towards improving treatment of drug resistant golden staph (MRSA) - a breakthrough that could potentially save hundreds of lives, every day.

  29. Infectious diseases specialist awarded $75 000 to continue fight against super-bug.

    Infectious diseases specialist awarded $75 000 to continue fight against super-bug.

    Date

    The grant will provide vital funding to develop trials in the areas of Staphylococcus aureus (golden Staph) infections, bone and joint infections and skin infections.

  30. Research reveals alarmingly high rates of the world’s second most deadly cancer in the NT

    Research reveals alarmingly high rates of the world’s second most deadly cancer in the NT

    Date

    A new study conducted by Menzies has found a very high prevalence of liver cancer in the NT.

  31. NHMRC career fellowship: Dr Josh Davis

    NHMRC career fellowship: Dr Josh Davis

    Date

    Menzies infectious diseases specialist, Dr Josh Davis was recently awarded a Career Development Fellowship as part of the National Health and Medical Research Council’s (NHMRC) yearly multi-million dollar funding round. Josh’s fellowship...

  32. NHMRC project snapshot: Dr Josh Davis

    NHMRC project snapshot: Dr Josh Davis

    Date

    Menzies infectious diseases specialist, Dr Josh Davis was recently awarded a competitive project grant as part of the National Health and Medical Research Council’s (NHMRC) yearly multi-million dollar funding round.

  33. NHMRC project snapshot: Dr Steve Tong

    NHMRC project snapshot: Dr Steve Tong

    Date

    Menzies' Post-doctoral Research Fellow Dr Steve Tong was recently awarded a competitive grant and a fellowship as part of the National Health and Medical Research Council's yearly multi-million dollar funding round.